[go: up one dir, main page]

AU2001272257A1 - Hcv mosaic antigen composition - Google Patents

Hcv mosaic antigen composition

Info

Publication number
AU2001272257A1
AU2001272257A1 AU2001272257A AU7225701A AU2001272257A1 AU 2001272257 A1 AU2001272257 A1 AU 2001272257A1 AU 2001272257 A AU2001272257 A AU 2001272257A AU 7225701 A AU7225701 A AU 7225701A AU 2001272257 A1 AU2001272257 A1 AU 2001272257A1
Authority
AU
Australia
Prior art keywords
hcv
antigen composition
mosaic antigen
diagnostic
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272257A
Other languages
English (en)
Inventor
Hermes K.W. Chan
Richard Theolis Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medmira Inc
Original Assignee
Medmira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medmira Inc filed Critical Medmira Inc
Publication of AU2001272257A1 publication Critical patent/AU2001272257A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001272257A 2000-07-07 2001-07-06 Hcv mosaic antigen composition Abandoned AU2001272257A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2311022 2000-07-07
CA2311022 2000-07-07
PCT/CA2001/000988 WO2002004484A2 (fr) 2000-07-07 2001-07-06 Composition d'antigene mosaique du virus de l'hepatite c (vhc)

Publications (1)

Publication Number Publication Date
AU2001272257A1 true AU2001272257A1 (en) 2002-01-21

Family

ID=4166420

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272257A Abandoned AU2001272257A1 (en) 2000-07-07 2001-07-06 Hcv mosaic antigen composition

Country Status (6)

Country Link
EP (1) EP1328811B1 (fr)
AT (1) ATE303597T1 (fr)
AU (1) AU2001272257A1 (fr)
DE (1) DE60113139T2 (fr)
ES (1) ES2248357T3 (fr)
WO (1) WO2002004484A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357127A1 (fr) * 2002-04-10 2003-10-29 Immusystems GmbH Epitopes du virus de l'hépatite C spécifiques à des lymphocytes T de type CD4+
US20040106526A1 (en) * 2002-12-03 2004-06-03 Baxter David Roderick Method for marking liquid hydrocarbons
EP2062590A1 (fr) * 2003-09-22 2009-05-27 Green Peptide Co., Ltd. Peptide dérivé du virus de l'hépatite C
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
US20090238822A1 (en) * 2005-10-13 2009-09-24 Virexx Medical Corp. Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response
JP2009018990A (ja) * 2005-10-25 2009-01-29 Univ Kurume Ｃ型肝炎ウイルス由来ペプチド
CN103091487A (zh) * 2005-11-12 2013-05-08 平台诊断有限公司 凝集分析法
CA2580589C (fr) 2006-12-19 2016-08-09 Fio Corporation Systeme de detection microfluidique
US20080227111A1 (en) 2007-03-16 2008-09-18 Sysmex Corporation Reagent kit and method for measuring hcv antibody
JP4975601B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
EP2209549A4 (fr) 2007-10-12 2014-03-05 Fio Corp Procédé de focalisation d'écoulement et système de création de volumes concentrés de microbilles, et microbilles formées à la suite de celui-ci
CA2729023C (fr) 2008-06-25 2013-02-26 Fio Corporation Systeme d'avertissement de menace biologique
WO2010022519A1 (fr) 2008-08-29 2010-03-04 Fio Corporation Dispositif de test de diagnostic portatif à usage unique, et système et procédé associés pour tester des échantillons biologiques et environnementaux
CN104374932A (zh) 2009-01-13 2015-02-25 Fio公司 与电子设备和快速诊断测试中的测试盒结合使用的手持诊断测试设备
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
EP3715374A1 (fr) 2019-03-23 2020-09-30 Ablevia biotech GmbH Composé de séquestration d'anticorps indésirables chez un patient
CN118818064A (zh) * 2024-08-23 2024-10-22 深圳上泰生物工程有限公司 一种抗磷脂酶a2受体抗体检测试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE206717T1 (de) * 1990-11-03 2001-10-15 Dade Behring Marburg Gmbh Hcv-spezifische peptide, mittel dazu und ihre verwendung
SG47062A1 (en) * 1990-12-14 1998-03-20 Innogenetics Nv Synthetic antigens for the detection of antibodies to hepatitis virus
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)

Also Published As

Publication number Publication date
DE60113139T2 (de) 2006-06-22
EP1328811B1 (fr) 2005-08-31
ES2248357T3 (es) 2006-03-16
DE60113139D1 (de) 2005-10-06
WO2002004484A2 (fr) 2002-01-17
ATE303597T1 (de) 2005-09-15
EP1328811A2 (fr) 2003-07-23
WO2002004484A3 (fr) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001272257A1 (en) Hcv mosaic antigen composition
FI112438B (fi) DNA-molekyyli ja menetelmä hepatiitti C-viruksen vastaisten vasta-aineiden ilmaisemiseksi
US7402315B2 (en) Hepatitis-C virus type 4, 5 and 6
US6217872B1 (en) Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
RU2001101869A (ru) Частицы белков оболочки HCV: применение для вакцинации
CA2045323C (fr) Adn-c du genome du virus de l'hepatite non-a, non-b et polypeptide antigenique
CA2184890A1 (fr) Peptides destines a induire des reponses de lymphocytes t cytotoxiques contre le virus de l'hepatite c
FR2794865A1 (fr) Methode de detection precoce des flavivirus et ses applications
EP0542970A1 (fr) Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques
CA2483945A1 (fr) Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
Yen et al. Cellular proteins specifically bind to the 5′-noncoding region of hepatitis C virus RNA
WO1996038474A3 (fr) Diagnostic de et vaccination contre un virus a arn double brin positif a l'aide d'un polypeptide isole et non traite
ES2143996T5 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
EP1806363A4 (fr) Méthode de détection de l'antigène s du virus de l'hépatite b
EP1878797A3 (fr) Peptides antigéniques pour le groupage du virus de l'hépatite C, kit comprenant ceux-ci et procédé de groupage les utilisant
CA2495456C (fr) Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications
FR2690921A1 (fr) Polypeptides de synthèse appartenant au virus de l'hépatite C (VHC) et utilisables notamment pour détecter ce dernier.
DK0551275T3 (da) Non-A non-B sekvenser
JP2005510211A5 (fr)
US5885771A (en) Antigenic peptide compound and immunoassay
US6447992B1 (en) Method for serological typing using type-specific antigens
IE922548A1 (en) Non-a, non-b peptide
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
WO1994013700A1 (fr) Peptides provenant de la region c33 du vhc, anticorps diriges contre ces peptides et procedes de detection du vhc
KR19990044211A (ko) 항원 펩타이드 화합물 및 면역학적 측정 방법